Align Technology | ALGN - 资产

股票价格
176.08
每天变化
-2.32 -1.30%
每月一次
2.71%
每年
-0.37%
Q2 预测
185.55


金融业
股票价格
USD
资产
USD 6.31B
现金及等价物
USD 1.09B
销售成本
USD 303.5M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 114.45M
EBIT
USD 178.05M
EBITDA
USD 260.87M
员工
20.95K
EPS每股收益
USD 2.58
股本和储备
USD 4.05B
销售毛利
USD 736.59M
债务利息支出
USD 16.05M
利息收入
USD 4.62M
贷款资金
USD 0
市值
USD 13.01B
净收入
USD 112.77M
营业费用
USD 862.03M
营业利润
USD 178.05M
普通股股本
USD 71.62M
PE价格收益
22.78
税前利润
USD 148.89M
销售收入
USD 1.04B
销售和管理费用
USD 465.34M
股票
USD 226.34M
贸易债权人
USD 123.72M
应收帐款人
USD 1.13B


资产 更改 日
3M USD 35.44B 2.3B 2026-03
Align Technology USD 6.31B 80.48M 2026-03
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Cardinal Health USD 56.69B 1.39B 2026-03
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
CVS Health USD 253.54B 1.79B 2025-12
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.43B 224M 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Henry Schein USD 11.22B 118M 2025-12
Idexx Laboratories USD 3.35B 35.95M 2025-12
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Masimo USD 1.7B 118.6M 2025-12
McKesson USD 84.19B 30M 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Solventum Corp USD 14.29B 321M 2025-12
Stryker USD 47.84B 787M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Veeva Systems USD 8.98B 882.19M 2025-12
Waters USD 5.08B 221.41M 2025-12
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03
Zoetis USD 15.47B 308M 2025-12